Acemannano (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Acemannano" in Italian language version.

refsWebsite
Global rank Italian rank
4th place
9th place
799th place
22nd place
2nd place
7th place
399th place
1,563rd place

doi.org

dx.doi.org

drugs.com

nih.gov

ncbi.nlm.nih.gov

  • L. Zhang, IR. Tizard, Activation of a mouse macrophage cell line by acemannan: the major carbohydrate fraction from Aloe vera gel., in Immunopharmacology, vol. 35, n. 2, Nov 1996, pp. 119-28, PMID 8956975.
  • N. Pugh, SA. Ross; MA. ElSohly; DS. Pasco, Characterization of Aloeride, a new high-molecular-weight polysaccharide from Aloe vera with potent immunostimulatory activity., in J Agric Food Chem, vol. 49, n. 2, Feb 2001, pp. 1030-4, PMID 11262067.
  • SA. Kruth, Biological response modifiers: interferons, interleukins, recombinant products, liposomal products., in Vet Clin North Am Small Anim Pract, vol. 28, n. 2, Mar 1998, pp. 269-95, PMID 9556849.
  • JK. Lee, MK. Lee; YP. Yun; Y. Kim; JS. Kim; YS. Kim; K. Kim; SS. Han; CK. Lee, Acemannan purified from Aloe vera induces phenotypic and functional maturation of immature dendritic cells., in Int Immunopharmacol, vol. 1, n. 7, Jul 2001, pp. 1275-84, PMID 11460308.
  • JB. Kahlon, MC. Kemp; N. Yawei; RH. Carpenter; WM. Shannon; BH. McAnalley, In vitro evaluation of the synergistic antiviral effects of acemannan in combination with azidothymidine and acyclovir., in Mol Biother, vol. 3, n. 4, Dec 1991, pp. 214-23, PMID 1662957.
  • D. Womble, JH. Helderman, The impact of acemannan on the generation and function of cytotoxic T-lymphocytes., in Immunopharmacol Immunotoxicol, vol. 14, n. 1-2, 1992, pp. 63-77, DOI:10.3109/08923979209009213, PMID 1597661.
  • AJ. Vlietinck, T. De Bruyne; S. Apers; LA. Pieters, Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection., in Planta Med, vol. 64, n. 2, Mar 1998, pp. 97-109, DOI:10.1055/s-2006-957384, PMID 9525100.
  • JS. Montaner, J. Gill; J. Singer; J. Raboud; R. Arseneau; BD. McLean; MT. Schechter; J. Ruedy, Double-blind placebo-controlled pilot trial of acemannan in advanced human immunodeficiency virus disease., in J Acquir Immune Defic Syndr Hum Retrovirol, vol. 12, n. 2, Jun 1996, pp. 153-7, PMID 8680886.
  • GK. King, KM. Yates; PG. Greenlee; KR. Pierce; CR. Ford; BH. McAnalley; IR. Tizard, The effect of Acemannan Immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas., in J Am Anim Hosp Assoc, vol. 31, n. 5, pp. 439-47, PMID 8542364.
  • C. Harris, K. Pierce; G. King; KM. Yates; J. Hall; I. Tizard, Efficacy of acemannan in treatment of canine and feline spontaneous neoplasms., in Mol Biother, vol. 3, n. 4, Dec 1991, pp. 207-13, PMID 1768373.
  • WR. Usinger, A comparison of antibody responses to veterinary vaccine antigens potentiated by different adjuvants., in Vaccine, vol. 15, n. 17-18, Dec 1997, pp. 1902-7, PMID 9413100.
  • I. Tizard, Use of immunomodulators as an aid to clinical management of feline leukemia virus-infected cats., in J Am Vet Med Assoc, vol. 199, n. 10, Nov 1991, pp. 1482-5, PMID 1724773.
  • MA. Sheets, BA. Unger; GF. Giggleman; IR. Tizard, Studies of the effect of acemannan on retrovirus infections: clinical stabilization of feline leukemia virus-infected cats., in Mol Biother, vol. 3, n. 1, Mar 1991, pp. 41-5, PMID 1648929.

pubchem.ncbi.nlm.nih.gov

oadoi.org